Zhengye Biotechnology Holding Limited (ZYBT)

Market Cap	45.00M -87.9%
Revenue (ttm)	16.64M -37.6%
Net Income	-9.98M
EPS	-0.21
Shares Out	47.39M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,742
Open	0.9776
Previous Close	0.9776
Day's Range	0.9400 - 0.9776
52-Week Range	0.6800 - 13.7900
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 28, 2026

About ZYBT

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Jan 7, 2025
• Employees: 277
• Stock Exchange: NASDAQ
• Ticker Symbol: ZYBT
• Website: https://www.jlzybio.com

Financial Performance

Financial numbers in CNY